Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Immucor to increase volume of shares:

This article was originally published in Clinica

Executive Summary

Immucor's existing shareholders are to receive a 50% stock dividend following the company's decision to go ahead with a 3-for-2 stock split. The move will increase the number of shares of common stock outstanding from over 20 million, as recorded at the end of May, to over 30 million. The expected date of distribution is July 16. Since received FDA approval for its fully automated Galileo blood sample analyser in April, the company saw its share price go up nearly 27%. According to the Norcross, Georgia-based company, the aim in increasing the number of shares is to make the price of its stock more accessible to investors of all levels. This is the sixth stock split for Immucor since its IPO in December 1985.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058709

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel